Cargando…
Response to: Ruxolitinib withdrawal due to the COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905976/ https://www.ncbi.nlm.nih.gov/pubmed/33633312 http://dx.doi.org/10.1038/s41375-021-01187-4 |
| _version_ | 1783655211162664960 |
|---|---|
| author | Barbui, Tiziano Carobbio, Alessandra |
| author_facet | Barbui, Tiziano Carobbio, Alessandra |
| author_sort | Barbui, Tiziano |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7905976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79059762021-02-26 Response to: Ruxolitinib withdrawal due to the COVID-19 Barbui, Tiziano Carobbio, Alessandra Leukemia Correspondence Nature Publishing Group UK 2021-02-25 2021 /pmc/articles/PMC7905976/ /pubmed/33633312 http://dx.doi.org/10.1038/s41375-021-01187-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Barbui, Tiziano Carobbio, Alessandra Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title | Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title_full | Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title_fullStr | Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title_full_unstemmed | Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title_short | Response to: Ruxolitinib withdrawal due to the COVID-19 |
| title_sort | response to: ruxolitinib withdrawal due to the covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905976/ https://www.ncbi.nlm.nih.gov/pubmed/33633312 http://dx.doi.org/10.1038/s41375-021-01187-4 |
| work_keys_str_mv | AT barbuitiziano responsetoruxolitinibwithdrawalduetothecovid19 AT carobbioalessandra responsetoruxolitinibwithdrawalduetothecovid19 |